Enliven Therapeutics, Inc.
ELVN
$58.82
$0.761.31%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 895.16M | 452.40M | 462.62M | 477.57M | 490.50M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 12.18M | 10.74M | 12.26M | 5.12M | 5.12M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 907.34M | 463.14M | 474.88M | 482.68M | 495.62M |
|
|
|||||
| Total Current Assets | 907.34M | 463.14M | 474.88M | 482.68M | 495.62M |
| Net Property, Plant & Equipment | 1.64M | 310.00K | 417.00K | 874.00K | 1.03M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.24M | 1.41M | 873.00K | 7.32M | 7.24M |
| Total Assets | 910.22M | 464.85M | 476.17M | 490.88M | 503.89M |
|
|
|||||
| Total Accounts Payable | 371.00K | 1.64M | 2.16M | 1.43M | 2.35M |
| Total Accrued Expenses | 13.06M | 9.44M | 13.66M | 12.75M | 12.42M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 597.00K | 302.00K | 399.00K | 387.00K | 376.00K |
| Total Finance Division Other Current Liabilities | 133.00K | 107.00K | 351.00K | 86.00K | 63.00K |
| Total Other Current Liabilities | 133.00K | 107.00K | 351.00K | 86.00K | 63.00K |
| Total Current Liabilities | 14.16M | 11.49M | 16.57M | 14.65M | 15.21M |
|
|
|||||
| Total Current Liabilities | 14.16M | 11.49M | 16.57M | 14.65M | 15.21M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 913.00K | -- | -- | 103.00K | 204.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 15.07M | 11.49M | 16.57M | 14.75M | 15.42M |
|
|
|||||
| Common Stock & APIC | 1.30B | 824.54M | 806.43M | 793.40M | 786.00M |
| Retained Earnings | -403.28M | -370.79M | -347.17M | -317.50M | -297.35M |
| Treasury Stock & Other | -1.91M | -382.00K | 334.00K | 221.00K | -177.00K |
| Total Common Equity | 895.15M | 453.37M | 459.60M | 476.12M | 488.47M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 895.15M | 453.37M | 459.60M | 476.12M | 488.47M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 895.15M | 453.37M | 459.60M | 476.12M | 488.47M |
|
|
|||||